Corpus ID: 55866742

Magnitude of contrast-enhancement of normal peripheral zone on 3.0T prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI): a study with different injection protocols using gadobenatedimeglumine (Gd-BOPTA)

@inproceedings{Bednarova2015MagnitudeOC,
  title={Magnitude of contrast-enhancement of normal peripheral zone on 3.0T prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI): a study with different injection protocols using gadobenatedimeglumine (Gd-BOPTA)},
  author={Iliana Bednarova},
  year={2015}
}
Poster: "ECR 2016 / C-1674 / Magnitude of contrast-enhancement of normal peripheral zone on 3.0T prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI): a study with different injection protocols using gadobenatedimeglumine (Gd-BOPTA)" by: "I. Bednarova, M. Zerial, L. Cereser, C. Zuiani, M. Bazzocchi, R. Girometti; Udine/IT" 

Figures and Tables from this paper

References

SHOWING 1-7 OF 7 REFERENCES
Evaluation of Normal Prostate Tissue, Chronic Prostatitis, and Prostate Cancer by Quantitative Perfusion Analysis Using a Dynamic Contrast-Enhanced Inversion-Prepared Dual-Contrast Gradient Echo Sequence
TLDR
The pharmacokinetic parameters investigated, especially perfusion, allow statistically significant in situ differentiation of normal prostate tissue from cancer and chronic prostatitis and of high-grade cancer from chronic prost atitis. Expand
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.
TLDR
The data suggest that the combination of T2W MRI and DWI or MRSI with DCE-MRI has the potential to guide biopsy to the most aggressive cancer foci in patients with previously negative biopsies, increasing the accuracy of the procedure. Expand
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
  • N. Hylton
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
TLDR
The general methodology for performing D CE-MRI is reviewed and existing data and challenges to applying DCE-MRI for treatment response assessment in clinical trials are discussed. Expand
Evaluation of the Prostate Imaging Reporting and Data System for the Detection of Prostate Cancer by the Results of Targeted Biopsy of the Prostate
TLDR
The PI-RADS scoring system shows a good diagnostic performance for the detection of prostate cancer when using a sum score and DCE-MRI does not seem to add significant value when evaluated according to the recommended criteria. Expand
Histology core‐specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate
To evaluate the Prostate Imaging Reporting and Data System (PIRADS) in multiparametric magnetic resonance imaging (mpMRI) based on single cores and single‐core histology. To calculate positive (PPV)Expand
Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology
To determine whether the combination of diffusion‐weighted (DW) and dynamic contrast‐enhanced (DCE) MRI provides higher diagnostic sensitivity for prostate cancer than each technique alone.
ESURprostate MRguidelines 2012,
  • European Radiology
  • 2012